For press inquiries click here to contact us.
Evonetix
Evonetix Developing Thermally Controlled Enzymatic DNA Synthesis
DNAnexus, Inc.
DNAnexus Raises $200M Financing, with Platform Expansion in Mind
Cue Health (Alumni)
How Cue Health’s Covid-19 Test Became the Go-To for Business
Element Biosciences Partners With Informatics Experts Sentieon and Google DeepVariant to Validate the AVITI™ System’s NGS Data Quality for Variant Calling
Element Biosciences
Element Biosciences acquires Loop Genomics to add long-read tech to DNA sequencing platform
Alumis, Inc. (Alumni)
Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis
Detect, Inc.
As Omicron Spreads, New PCR-Like At-Home Covid Tests Provide Fast, Accurate Results
ImmPACT Bio, Inc.
Novartis-backed ImmPACT Bio snags $111M and new CEO as cancer CAR-T yields phase 1 results
Eikon Therapeutics
‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M
Please see important disclaimers in the Terms section.
